Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Wed Feb 4, 4:18AM CST

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €47.50.

Claim 50% Off TipRanks Premium

According to TipRanks, Al-Wakeel is a 2-star analyst with an average return of 0.5% and a 50.00% success rate. Al-Wakeel covers the Healthcare sector, focusing on stocks such as Smith & Nephew, Straumann Holding AG, and EssilorLuxottica SA.

In addition to Barclays, Fresenius Medical Care AG & Co. KGaA also received a Hold from Deutsche Bank ‘s Falko Friedrichs in a report issued on January 26. However, yesterday, Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See today’s best-performing stocks on TipRanks >>

0H9X market cap is currently €11.02B and has a P/E ratio of 15.46.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).